Cargando…
Building Team Medicine in the Management of CNS Metastases
CNS metastases are often terminal for cancer patients and occur at an approximately 10-fold higher rate than primary CNS tumors. The incidence of these tumors is approximately 70,000–400,000 cases annually in the US. Advances that have occurred over the past two decades have led to more personalized...
Autores principales: | Baskaran, Archit B., Buerki, Robin A., Khan, Osaama H., Gondi, Vinai, Stupp, Roger, Lukas, Rimas V., Villaflor, Victoria M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299499/ https://www.ncbi.nlm.nih.gov/pubmed/37373596 http://dx.doi.org/10.3390/jcm12123901 |
Ejemplares similares
-
Secondary CNS myeloma with remission after systemic CNS-penetrating agents
por: Fernandez, Luis G, et al.
Publicado: (2022) -
Case Report of Bone Marrow-Sparing Proton Therapy Craniospinal Irradiation for Central Nervous System Myelomatosis
por: Kauffmann, Greg, et al.
Publicado: (2017) -
Using methylation profiling to diagnose systemic metastases of pleomorphic xanthoastrocytoma
por: Kam, Kwok-Ling, et al.
Publicado: (2019) -
State-of-the-art considerations in small cell lung cancer brain metastases
por: Lukas, Rimas V., et al.
Publicado: (2017) -
Advances in radiotherapy for brain metastases
por: Gondi, Vinai, et al.
Publicado: (2021)